Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 748742, 6 pages
http://dx.doi.org/10.1155/2014/748742
Research Article

Concomitant Intake of Quercetin with a Grain-Based Diet Acutely Lowers Postprandial Plasma Glucose and Lipid Concentrations in Pigs

Institute of Animal Nutrition and Physiology, Christian-Albrechts-University of Kiel, Hermann-Rodewald-Straße 9, 24118 Kiel, Germany

Received 5 February 2014; Accepted 31 March 2014; Published 16 April 2014

Academic Editor: Ajit S. Narang

Copyright © 2014 Silvia Wein and Siegfried Wolffram. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. S. Visscher and J. C. Seidell, “The public health impact of obesity,” Annual Review of Public Health, vol. 22, pp. 355–375, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. “Standards of medical care in diabetes—2008,” Diabetes Care, vol. 31, supplement 1, pp. S12–S54, 2008.
  4. J. Pang, D. C. Chan, P. H. R. Barrett, and G. F. Watts, “Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspects,” Current Opinion in Lipidology, vol. 23, pp. 303–309, 2012. View at Google Scholar
  5. S. Pastromas, A.-B. Terzi, D. Tousoulis, and S. Koulouris, “Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus,” International Journal of Cardiology, vol. 126, no. 1, pp. 3–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Boden and M. Laakso, “Lipids and glucose in type 2 diabetes: what is the cause and effect?” Diabetes Care, vol. 27, no. 9, pp. 2253–2259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Miles, D. Wooldridge, W. J. Grellner et al., “Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy,” Diabetes, vol. 52, no. 3, pp. 675–681, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tibaldi, “Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes,” Southern Medical Journal, vol. 102, no. 1, pp. 60–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Vargas-Murga, A. Garcia-Alvarez, B. Roman-Viñas et al., “Plant food supplement (PFS) market structure in EC Member States, methods and techniques for the assessment of individual PFS intake,” Food and Function, vol. 2, no. 12, pp. 731–739, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Kwon, P. Eck, S. Chen et al., “Inhibition of the intestinal glucose transporter GLUT2 by flavonoids,” FASEB Journal, vol. 21, no. 2, pp. 366–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. X.-K. Fang, J. Gao, and D.-N. Zhu, “Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity,” Life Sciences, vol. 82, no. 11-12, pp. 615–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Kumazawa, K. Kawaguchi, and H. Takimoto, “Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor α,” Current Pharmaceutical Design, vol. 12, no. 32, pp. 4271–4279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Naumann, R. Bassler, and R. B. C. Seibold, “Die chemische Untersuchung von Futtermitteln,” in Methodenbuch Band III, Verband Deutscher Landwirtschaftlicher Untersuchungs Und Forschungsanstalten (VDLUFA), VDLUFA, Darmstadt, Germany, 3 edition, 1997. View at Google Scholar
  14. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  15. B. A. Graf, P. E. Milbury, and J. B. Blumberg, “Flavonols, flavones, flavanones, and human health: epidemiological evidence,” Journal of Medicinal Food, vol. 8, no. 3, pp. 281–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Barnes, “Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety,” British Journal of Clinical Pharmacology, vol. 55, no. 4, pp. 331–340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Barnes, “Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality,” British Journal of Clinical Pharmacology, vol. 55, no. 3, pp. 226–233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Middleton, “Biological properties of plant flavonoids: an overview,” International Journal of Pharmacognosy, vol. 34, no. 5, pp. 344–348, 1996. View at Google Scholar · View at Scopus
  19. L. G. Miller, “Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions,” Archives of Internal Medicine, vol. 158, no. 20, pp. 2200–2211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Lesser and S. Wolffram, “Oral bioavailability of the flavonol quercetin—a review,” Current Topics in Nutraceutical Research, vol. 4, no. 3-4, pp. 239–256, 2006. View at Google Scholar · View at Scopus
  21. B. A. Graf, W. Mullen, S. T. Caldwell et al., “Disposition and metabolism of [2-14C]quercetin-4′- glucoside in rats,” Drug Metabolism and Disposition, vol. 33, no. 7, pp. 1036–1043, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Ader, A. Wessmann, and S. Wolffram, “Bioavailability and metabolism of the flavonol quercetin in the pig,” Free Radical Biology and Medicine, vol. 28, no. 7, pp. 1056–1067, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. E. U. Graefe, J. Wittig, S. Mueller et al., “Pharmacokinetics and bioavailability of quercetin glycosides in humans,” Journal of Clinical Pharmacology, vol. 41, no. 5, pp. 492–499, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Reinboth, S. Wolffram, G. Abraham, F. R. Ungemach, and R. Cermak, “Oral bioavailability of quercetin from different quercetin glycosides in dogs,” British Journal of Nutrition, vol. 104, no. 2, pp. 198–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Wein and S. Wolffram, “Oral bioavailability of quercetin in horses,” Journal of Equine Veterinary Science, vol. 33, pp. 441–445, 2013. View at Google Scholar
  26. L. H. Cazarolli, L. Zanatta, E. H. Alberton et al., “Flavonoids: prospective drug candidates,” Mini Reviews in Medicinal Chemistry, vol. 8, no. 13, pp. 1429–1440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-H. Kim, M.-J. Kang, H.-N. Choi, S.-M. Jeong, Y.-M. Lee, and J.-I. Kim, “Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus,” Nutrition Research and Practice, vol. 5, no. 2, pp. 107–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Q. Li, F. C. Zhou, F. Gao, J. S. Bian, and F. Shan, “Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase,” Journal of Agricultural and Food Chemistry, vol. 57, no. 24, pp. 11463–11468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-W. M. Breuer, “Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes,” International Journal of Clinical Pharmacology and Therapeutics, vol. 41, no. 10, pp. 421–440, 2003. View at Google Scholar · View at Scopus
  30. G. L. Kellett, E. Brot-Laroche, O. J. Mace, and A. Leturque, “Sugar absorption in the intestine: the role of GLUT2,” Annual Review of Nutrition, vol. 28, pp. 35–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Cermak, S. Landgraf, and S. Wolffram, “Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum,” British Journal of Nutrition, vol. 91, no. 6, pp. 849–855, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Song, O. Kwon, S. Chen et al., “Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose,” Journal of Biological Chemistry, vol. 277, no. 18, pp. 15252–15260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Baggio, C. S. Freitas, B. Mayer et al., “Muscarinic-dependent inhibition of gastric emptying and intestinal motility by fractions of Maytenus ilicifolia Mart ex. Reissek,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 385–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. I. E. Chazova and B. B. Mychka, “Metabolic syndrome treatment: focusing on acarbose,” Cardiovascular Therapy and Prevention, vol. 7, pp. 60–64, 2008. View at Google Scholar
  35. D. Brewer, “Are alpha-glucosidase inhibitors effective for control of type 2 diabetes?” American Family Physician, vol. 73, no. 3, pp. 433–3, 2006. View at Google Scholar · View at Scopus
  36. G. Derosa and P. Maffioli, “Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review,” Clinical Therapeutics, vol. 34, pp. 1221–1236, 2012. View at Google Scholar
  37. A. Jenney, J. Proietto, K. O'Dea, A. Nankervis, K. Traianedes, and H. D'Embden, “Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity,” Diabetes Care, vol. 16, no. 2, pp. 499–502, 1993. View at Google Scholar · View at Scopus
  38. S. Okada, K. Ishii, S. Tanokuchi, H. Hamada, K. Ichiki, and Z. Ota, “Effect of α-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus,” Journal of International Medical Research, vol. 23, no. 6, pp. 492–496, 1995. View at Google Scholar · View at Scopus
  39. S. Wein, N. Behm, R. K. Petersen, K. Kristiansen, and S. Wolffram, “Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism,” European Journal of Pharmaceutical Sciences, vol. 41, no. 1, pp. 16–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S.-H. Bok, S.-Y. Park, B. P. Yong et al., “Quercetin dihydrate and gallate supplements lower plasma and hepatic lipids and change activities of hepatic antioxidant enzymes in high cholesterol-fed rats,” International Journal for Vitamin and Nutrition Research, vol. 72, no. 3, pp. 161–169, 2002. View at Google Scholar · View at Scopus
  41. N. K. Gabler, E. Ostrowska, S. J. Sterling et al., “Consumption of raw brown onions variably modulate plasma lipid profile and lipoprotein oxidation in pigs fed a high-fat diet,” Journal of the Science of Food and Agriculture, vol. 85, no. 1, pp. 154–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Pfeuffer, A. Auinger, U. Bley et al., “Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammatory parameters in men with different APOE isoforms,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, pp. 403–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Sergent, J. Vanderstraeten, J. Winand, P. Beguin, and Y. J. Schneider, “Phenolic compounds and plant extracts as potential natural anti-obesity substances,” Food Chemistry, vol. 135, pp. 68–73, 2012. View at Google Scholar